Last $27.60 USD
Change Today +0.39 / 1.43%
Volume 488.6K
EXAS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for exact sciences corp (EXAS)

Year over year, Exact Sciences Corporation has seen revenues remain relatively flat ($4.1M USD to $4.1M USD), though the company was able to grow net income from a loss of $52.4M USD to a smaller loss of $46.5M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Restated
Dec 31
2011
Restated
Dec 31
2012
Dec 31
2013
4 Year
Trend
Revenues5.34.24.14.1
TOTAL REVENUES5.34.24.14.1
Cost of Goods Sold0.00.0----
GROSS PROFIT5.34.14.14.1
Selling General & Admin Expenses, Total8.111.014.723.2
R&D Expenses9.022.042.127.7
OTHER OPERATING EXPENSES, TOTAL17.133.056.850.9
OPERATING INCOME-11.8-28.8-52.6-46.8
Interest Expense0.00.00.0-0.1
Interest and Investment Income0.00.20.30.3
NET INTEREST EXPENSE0.00.10.20.2
Other Non-Operating Income (Expenses)0.2------
EBT, EXCLUDING UNUSUAL ITEMS-11.6-28.7-52.4-46.5
EBT, INCLUDING UNUSUAL ITEMS-11.6-28.7-52.4-46.5
Earnings from Continuing Operations-11.6-28.7-52.4-46.5
NET INCOME-11.6-28.7-52.4-46.5
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-11.6-28.7-52.4-46.5
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-11.6-28.7-52.4-46.5
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXAS:US $27.60 USD +0.39

EXAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CTI BioPharma Corp $2.36 USD +0.05
Curis Inc $1.29 USD +0.04
Delcath Systems Inc $1.36 USD +0.0068
MELA Sciences Inc $1.25 USD +0.02
Navidea Biopharmaceuticals Inc $2.00 USD +0.02
View Industry Companies
 

Industry Analysis

EXAS

Industry Average

Valuation EXAS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,619.5x
Price/Book 10.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,570.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXACT SCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.